Sari Fishman
Corporate Officer/Principal presso CAN-FITE BIOPHARMA LTD.
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di Sari Fishman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CAN-FITE BIOPHARMA LTD. | Corporate Officer/Principal | 01/01/2014 | - |
| Direttore Tecnico/Scientifico/R&S | 01/01/2004 | 01/01/2014 |
Storia della carriera di Sari Fishman
Precedenti posizioni note di Sari Fishman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Sari Fishman
| Bar-Ilan University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Israele | 4 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CAN-FITE BIOPHARMA LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
- Borsa valori
- Insiders
- Sari Fishman
- Esperienza
